Retrospective study of drug therapy in malignant pleural mesothelioma(NEJ065)

UMIN ID: UMIN000055676

Registered date:30/09/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: malignant pleural mesothelioma
• Date of first enrollment: 2024/09/04
• Target sample size: 1000
• Countries of recruitment: Japan
• Study type: Observational

Outcome(s)

• Primary Outcome: gender,age,PS/height,and weight at start of drug therapy regimen,Any history of asbestos exposure (if any, specific occupation)
• Secondary Outcome: Histological types (epithelial,sarcomatoid,biphasic,other),UICC TNM classification (III,I,Vpostoperative recurrence,recurrence after chemoradiotherapy),presence of pleural effusion,Blood test findings (neutrophil count,lymphocyte count,platelet count,serum albumin,CRP,LDH)

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1.Patients enrolled in prospective clinical trials (intervention studies) 2.Patients deemed inappropriate by the physician in charge for reasons such as inability to collect the information necessary to complete the Case Report Form (CRF).

Related Information

• Primary Sponsor: Saitama Medical University International Medical Center
• Source(s) of Monetary Support: nil